Letter

Office of NHS cancer screening programme misrepresents Nordic work in breast screening row

BMJ 2001; 323 doi: 10.1136/bmj.323.7321.1131/a (Published 10 November 2001)
Cite this as: BMJ 2001;323:1131.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter C Gøtzsche, director (pcg@cochrane.dk)
  1. Nordic Cochrane Centre, Rigshospitalet, DK-2100 Copenhagen ø, Denmark

    EDITOR—In Mayor's news story in the issue of 27 October the office of the NHS cancer screening programme in the United Kingdom misrepresents our research entirely.1 The office says that our findings of more aggressive treatment of breast cancer among screened women are based on only two studies, classified as poor quality. They are not. Numbers of mastectomies as well as numbers of tumourectomies increase when women are screened. This finding is consistent and is based on all four of the seven screening trials that have published data on this, including the two medium quality trials from Canada and Malmö.2

    The office …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular